Clinical Trials Logo

Atrium; Fibrillation clinical trials

View clinical trials related to Atrium; Fibrillation.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05633303 Recruiting - Clinical trials for Atrium; Fibrillation

Personalised Ablation Strategies in AF

PAS
Start date: October 14, 2022
Phase: N/A
Study type: Interventional

Atrial fibrillation (AF) is the most common arrhythmia with an expected rise in prevalence over the next decade. Catheter ablation is a safe treatment option in eliminating AF however, success rates still remains variable. Existing strategies do not take into account the differences in AF perpetuation mechanisms beyond the pulmonary veins (PVs) due to the underlying substrate. Here, I will investigate the differences in persistent AF mechanisms due to the underlying substrate and utilise these findings to generate AF mechanism specific ablation strategies. I have defined a new metric, rate-dependent conduction velocity (RDCV) slowing that has shown to correlate with sites of re-entry activity in AF. In this study, techniques and methods will be developed to measure RDCV slowing sites. The impact autonomic modulation has on AF mechanisms and CV dynamics will also be assessed. The hypothesis is that a combination of structural, electrical and autonomic remodelling play an important mechanistic role in persistent AF and ablation strategies adapted to target these will result in greater procedural success rate. The study findings have the potential to improve the success rate of catheter ablation in persistent AF thereby improve patient wellbeing and reduce the cost burden of AF treatment.

NCT ID: NCT05456204 Recruiting - Clinical trials for Atrium; Fibrillation

Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Catheter Ablation

Start date: February 15, 2022
Phase: N/A
Study type: Interventional

It is planned to evaluate the efficacy and safety of the class III antiarrhythmic drug refralon as a drug for pharmacological cardioversion in patients with recurrent atrial fibrillation (AF) and atrial flutter (AFL) after catheter ablation.

NCT ID: NCT05434650 Recruiting - Atrial Arrhythmia Clinical Trials

Abbott Atrial Fibrillation Post Approval Study

Start date: October 21, 2022
Phase:
Study type: Observational

This post-approval study is designed to provide continued real-world clinical evidence to confirm the safety and long-term effectiveness of atrial fibrillation (AF) radiofrequency (RF) technologies (e.g. TactiCathâ„¢ Contact Force Ablation Catheter, Sensor Enabledâ„¢ (TactiCath SE)) for the treatment of AF.

NCT ID: NCT04545437 Recruiting - Stroke Clinical Trials

The Short and Long-term Cardiovascular Consequences of Critical Illness: The C3 Study

C3
Start date: August 10, 2020
Phase:
Study type: Observational

The aim this study will be to find out which patients are at risk of heart attacks/strokes up to several years after discharge from an ICU. This study will also investigate whether treatments and events occurring in ICU contribute to this risk.

NCT ID: NCT03487419 Recruiting - Clinical trials for Atrium; Fibrillation

Echocardiographic Left Atrial Function Assessment and Atrial Fibrillation Post-Coronary Artery Bypass Surgery

Start date: August 1, 2018
Phase:
Study type: Observational [Patient Registry]

The aim of this study to investigate the correlation between preoperative LA function using 2D echocardiography and left atrium 2D speckle tracking strain echocardiography and the development of Post Operative AF after CABG. the investigators chose electrocardiography as a reference standard for detection of Post Operative AF. LA dysfunction is diagnosed with Echocardiography